pilocarpine has been researched along with ketamine in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (12.00) | 18.2507 |
| 2000's | 12 (48.00) | 29.6817 |
| 2010's | 8 (32.00) | 24.3611 |
| 2020's | 2 (8.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Fujikawa, DG | 1 |
| Belluardo, N; Bindoni, M; Jiang, XH; Mudò, G; Timmusk, T | 1 |
| Broźek, G; Hort, J; Komárek, V; Langmeier, M; Mares, P | 1 |
| Cook, LL | 1 |
| Pobuts'kyĭ, OO | 1 |
| Persinger, MA; St-Pierre, LS | 1 |
| McKay, BE; Persinger, MA | 2 |
| Gillessen, T; Grasshoff, C; Szinicz, L; Thiermann, H; Wagner, E | 1 |
| Fonteles, MM; Freitas, RM; Sousa, FC; Viana, GS | 1 |
| Assis, MA; Fonteles, MM; Freitas, RL; Freitas, RM; Pereira, MB; Silva, RF; Takahashi, RN | 1 |
| Kapur, J; Martin, BS | 1 |
| Blomme, CG; Dupont, MJ; George, KR; Mazzuchin, A; Persinger, MA; Rico, T; St-Pierre, LS; Stewart, LS | 1 |
| Cunha, AO; dos Santos, WF; Liberato, JL; Mortari, MR | 1 |
| Aourz, N; Clinckers, R; De Bundel, D; Meurs, A; Michotte, Y; Portelli, J; Smolders, I | 1 |
| Denisov, AB | 1 |
| Córdova, SD; de Oliveira, DL; Loss, CM | 1 |
| Löscher, W | 1 |
| Baldwin, R; Lumley, L; Niquet, J; Norman, K; Suchomelova, L; Wasterlain, CG | 1 |
| Avoli, M; Lévesque, M; Wang, S | 2 |
| Baldwin, R; Estrada, IBF; Furtado, MA; Lumley, L; Naylor, D; Niquet, J; Rossetti, F; Schultz, M; Suchomelova, L; Wasterlain, CG | 1 |
| Chniguir, A; Dang, PM; El-Benna, J; Eto, B; Pintard, C; Souilem, O; Tannich, F; Tlili, A | 1 |
3 review(s) available for pilocarpine and ketamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Single versus combinatorial therapies in status epilepticus: Novel data from preclinical models.
Topics: Animals; Anticonvulsants; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Ketamine; Lithium; Phenobarbital; Pilocarpine; Rats; Seizures; Status Epilepticus | 2015 |
Rational polytherapy in the treatment of cholinergic seizures.
Topics: Animals; Anticonvulsants; Cholinesterase Inhibitors; Drug Therapy, Combination; Ketamine; Male; Midazolam; Muscarinic Agonists; Nerve Agents; Pilocarpine; Rats; Rats, Sprague-Dawley; Soman; Status Epilepticus; Valproic Acid | 2020 |
22 other study(ies) available for pilocarpine and ketamine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neuroprotective effect of ketamine administered after status epilepticus onset.
Topics: Amygdala; Animals; Brain; Cell Death; Electroencephalography; Frontal Lobe; Injections, Intraperitoneal; Ketamine; Lithium Chloride; Male; Pilocarpine; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Status Epilepticus | 1995 |
Change in neurotrophins and their receptor mRNAs in the rat forebrain after status epilepticus induced by pilocarpine.
Topics: Animals; Brain-Derived Neurotrophic Factor; Cerebral Cortex; Gene Expression; Hippocampus; In Situ Hybridization; Ketamine; Lithium Chloride; Male; Nerve Growth Factors; Nerve Tissue Proteins; Neurotrophin 3; Pilocarpine; Prosencephalon; Protein-Tyrosine Kinases; Rats; Rats, Wistar; RNA, Messenger; Scopolamine; Status Epilepticus; Tissue Distribution | 1996 |
Cognitive functions after pilocarpine-induced status epilepticus: changes during silent period precede appearance of spontaneous recurrent seizures.
Topics: Animals; Cell Count; Clonazepam; Cognition; Hippocampus; Ketamine; Male; Maze Learning; Memory; Pilocarpine; Rats; Rats, Long-Evans; Status Epilepticus | 1999 |
Ventricular enlargement and the lithium/pilocarpine seizure model: possible explanation for agonistic behaviour.
Topics: Acepromazine; Agonistic Behavior; Animals; Anticonvulsants; Ketamine; Lateral Ventricles; Lithium; Male; Pilocarpine; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Seizures | 2000 |
[Application of synthetic neuropeptides in complex of surgical treatment of acute pancreatitis and its complication].
Topics: Acute Disease; Animals; Cats; Combined Modality Therapy; Drug Administration Schedule; Enkephalin, Leucine-2-Alanine; Excitatory Amino Acid Antagonists; Gastrointestinal Agents; Injections, Intramuscular; Ketamine; Male; Muscarinic Agonists; Pancreatitis; Pilocarpine | 2002 |
The brain matrix and multifocal brain damage following a single injection of ketamine in young adult rats: conspicuous changes in old age.
Topics: Acepromazine; Age Factors; Animals; Brain; Brain Damage, Chronic; Disease Models, Animal; Ketamine; Lithium; Male; Neurons; Pilocarpine; Rats; Rats, Wistar; Seizures | 2002 |
Normal spatial and contextual learning for ketamine-treated rats in the pilocarpine epilepsy model.
Topics: Animals; Disease Models, Animal; Epilepsy; Ketamine; Male; Maze Learning; Pilocarpine; Rats; Rats, Wistar | 2004 |
Ketamine reduces cholinergic modulated GABA release from rat striatal slices.
Topics: Animals; Corpus Striatum; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Interactions; Electrophysiology; Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid; In Vitro Techniques; Ketamine; Male; Muscarinic Agonists; Muscarinic Antagonists; Pilocarpine; Pirenzepine; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate | 2005 |
Weak, physiologically patterned magnetic fields do not affect maze performance in normal rats, but disrupt seized rats normalized with ketamine: possible support for a neuromatrix concept?
Topics: Analgesics; Animals; Behavior, Animal; Brain; Disease Models, Animal; Electromagnetic Fields; Ketamine; Male; Maze Learning; Memory; Pilocarpine; Rats; Rats, Wistar; Seizures | 2006 |
Effect of gabaergic, glutamatergic, antipsychotic and antidepressant drugs on pilocarpine-induced seizures and status epilepticus.
Topics: Amines; Amitriptyline; Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Cyclohexanecarboxylic Acids; Excitatory Amino Acid Antagonists; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Humans; Ketamine; Male; Muscarinic Agonists; N-Methylaspartate; Pilocarpine; Pimozide; Rats; Seizures; Status Epilepticus | 2006 |
Study pharmacologic of the GABAergic and glutamatergic drugs on seizures and status epilepticus induced by pilocarpine in adult Wistar rats.
Topics: Amines; Animals; Anticonvulsants; Cyclohexanecarboxylic Acids; Excitatory Amino Acid Antagonists; Gabapentin; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Ketamine; Male; Muscarinic Agonists; N-Methylaspartate; Phenobarbital; Pilocarpine; Rats; Rats, Wistar; Receptors, GABA; Receptors, Neurotransmitter; Seizures; Status Epilepticus; Vigabatrin | 2007 |
A combination of ketamine and diazepam synergistically controls refractory status epilepticus induced by cholinergic stimulation.
Topics: Animals; Cerebral Cortex; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Electroencephalography; Excitatory Amino Acid Antagonists; Hippocampus; Ketamine; Lithium Compounds; Male; Muscarinic Agonists; Pilocarpine; Rats; Rats, Sprague-Dawley; Status Epilepticus; Treatment Outcome | 2008 |
Large differences in blood measures, tissue weights, and focal areas of damage 1 year after postseizure treatment with acepromazine or ketamine.
Topics: Acepromazine; Analysis of Variance; Animals; Blood Pressure; Brain; Disease Models, Animal; Dopamine Antagonists; Excitatory Amino Acid Antagonists; Female; Ketamine; Lithium Chloride; Longitudinal Studies; Male; Neurologic Examination; Organ Size; Pilocarpine; Rats; Rats, Wistar; Seizures; Statistics as Topic; Thyroid Gland | 2009 |
Neuroprotective effects of diazepam, carbamazepine, phenytoin and ketamine after pilocarpine-induced status epilepticus.
Topics: Animals; Anticonvulsants; Carbamazepine; Dentate Gyrus; Diazepam; Drug Administration Schedule; Glial Fibrillary Acidic Protein; Hippocampus; Ketamine; Male; Maze Learning; Neuroprotective Agents; Phenytoin; Pilocarpine; Rats; Rats, Wistar; Status Epilepticus | 2009 |
Intrastrain differences in seizure susceptibility, pharmacological response and basal neurochemistry of Wistar rats.
Topics: Analysis of Variance; Anesthetics, Dissociative; Animals; Biogenic Monoamines; Body Weight; Brain; Brain Chemistry; Chi-Square Distribution; Chromatography, Reverse-Phase; Disease Models, Animal; gamma-Aminobutyric Acid; Hippocampus; Ketamine; Male; Microdialysis; Pilocarpine; Rats; Rats, Wistar; Retrospective Studies; Seizures; Species Specificity | 2009 |
Method of assessment of the dynamics of salivary function in rats during the experiment.
Topics: Anesthetics, Dissociative; Animals; Female; Ketamine; Male; Muscarinic Agonists; Pilocarpine; Prostatitis; Rats; Salivary Glands; Salivation | 2011 |
Ketamine reduces neuronal degeneration and anxiety levels when administered during early life-induced status epilepticus in rats.
Topics: Animals; Anxiety; Brain; Convulsants; Ketamine; Male; Nerve Degeneration; Neuroprotective Agents; Pilocarpine; Rats; Rats, Wistar; Status Epilepticus | 2012 |
Midazolam-ketamine dual therapy stops cholinergic status epilepticus and reduces Morris water maze deficits.
Topics: Animals; Anticonvulsants; Brain; Cholinergic Agents; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Ketamine; Learning Disabilities; Lithium Chloride; Male; Maze Learning; Midazolam; N-Methylscopolamine; Pilocarpine; Rats; Rats, Sprague-Dawley; Status Epilepticus; Valproic Acid | 2016 |
Transition from status epilepticus to interictal spiking in a rodent model of mesial temporal epilepsy.
Topics: Animals; Anticonvulsants; Brain Waves; Diazepam; Disease Models, Animal; Drug Combinations; Electroencephalography; Epilepsy, Temporal Lobe; Hippocampus; Ketamine; Mice; Mice, Inbred C57BL; Pilocarpine; Status Epilepticus | 2019 |
Activation of the phagocyte NADPH oxidase/NOX2 and myeloperoxidase in the mouse brain during pilocarpine-induced temporal lobe epilepsy and inhibition by ketamine.
Topics: Animals; Brain; Disease Models, Animal; Epilepsy, Temporal Lobe; Excitatory Amino Acid Antagonists; Ketamine; Mice; NADPH Oxidase 2; NADPH Oxidases; Peroxidase; Phagocytes; Phosphorylation; Pilocarpine; Reactive Oxygen Species | 2020 |
Effects of Diazepam and Ketamine on Pilocarpine-Induced Status Epilepticus in Mice.
Topics: Animals; Anticonvulsants; Diazepam; Electroencephalography; Hippocampus; Ketamine; Mice; Pilocarpine; Status Epilepticus | 2019 |